Evidence map›Paper›PMID 38034851›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer's disease and related dementia research.

Gabrielle B Britton, Li-Kai Huang, Alcibiades E Villarreal, Allan Levey, Anthony Philippakis, Chaur-Jong Hu, Cheng Chang Yang, Declare Mushi, Diana C Oviedo, Giselle Rangel and 13 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 11 institutions in 5 countries.

Gabrielle B BrittonInstituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP) Panamá City Panama.
Li-Kai HuangTaipei Medical University Shuang-Ho Hospital Taipei Taiwan.
Alcibiades E VillarrealInstituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP) Panamá City Panama.
Allan LeveyEmory University School of Medicine Atlanta Georgia USA.
Anthony PhilippakisBroad Institute at Massachusetts Institute of Technology and Harvard University Cambridge Massachusetts USA.
Chaur-Jong HuTaipei Medical University Shuang-Ho Hospital Taipei Taiwan.
Cheng Chang YangTaipei Medical University Shuang-Ho Hospital Taipei Taiwan.
Declare MushiKilimanjaro Christian Medical University College Moshi Tanzania.
Diana C OviedoInstituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP) Panamá City Panama.
Giselle RangelInstituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP) Panamá City Panama.
Jor Sam HoDavos Alzheimer's Collaborative Wayne Pennsylvania USA.
Louisa ThompsonDavos Alzheimer's Collaborative Wayne Pennsylvania USA.
Mahdi KhemakhemDavos Alzheimer's Collaborative Wayne Pennsylvania USA.
Makayla RossDavos Alzheimer's Collaborative Wayne Pennsylvania USA.
María B CarreiraInstituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP) Panamá City Panama.
Nicole KimDavos Alzheimer's Collaborative Wayne Pennsylvania USA.
Philip JoungDavos Alzheimer's Collaborative Wayne Pennsylvania USA.
Omar AlbastakiDavos Alzheimer's Collaborative Wayne Pennsylvania USA.
Po Chih KuoNational Tsing Hua University, East District HsinChu Taiwan.
Spencer LowDavos Alzheimer's Collaborative Wayne Pennsylvania USA.
Stella-Maria PaddickGateshead Health NHS Foundation Trust Gateshead UK.
Yi-Chun KuanTaipei Medical University Shuang-Ho Hospital Taipei Taiwan.
Rhoda AuDavos Alzheimer's Collaborative Wayne Pennsylvania USA.
Taipei Medical University-Shuang Ho Hospital · TWBoston University · USInstituto de Investigaciones Científicas y Servicios de Alta Tecnología · PAUniversidad Católica Santa María La Antigua · PABrown University · USEmory University · USFramingham Heart Study · USGateshead Health NHS Foundation Trust · GBKilimanjaro Christian Medical Centre · TZMassachusetts Institute of Technology · USNational Tsing Hua University · TW

Funding

TBDU19AG068753 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Lindsay A. Farrer · 2020 to 2026
$42.4M
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study: Black & AA Recruitment SupplementRF1AG072654 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, GOLDSTEIN, LEE E. · 2021 to 2023
$2.4M
Cognitive Heterogeneity in those with high Alzheimer's Disease RiskRF1AG062109 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 2020 to 2021
$1.8M
Cognitive heterogeneity in those with high Alzheimer's Disease RiskR01AG062109 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Rhoda Au, Vijaya B. Kolachalama · 2025 to 2026
$1.6M
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham StudyR01AG072654 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Rhoda Au, LEE E. GOLDSTEIN · 2025 to 2026
$1.1M
Cognitive heterogeneity in those with high Alzheimer's Disease RiskR56AG062109 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 2018 to 2018
$517k
NIA NIH HHS R01 AG062109NIA NIH HHS R01 AG072654NIA NIH HHS R56 AG062109NIA NIH HHS RF1 AG062109NIA NIH HHS RF1 AG072654NIA NIH HHS U19 AG068753
6 · The paper itself

Abstract

A rapidly aging world population is fueling a concomitant increase in Alzheimer's disease (AD) and related dementias (ADRD). Scientific inquiry, however, has largely focused on White populations in Australia, the European Union, and North America. As such, there is an incomplete understanding of AD in other populations. In this perspective, we describe research efforts and challenges of cohort studies from three regions of the world: Central America, East Africa, and East Asia. These cohorts are engaging with the Davos Alzheimer's Collaborative (DAC), a global partnership that brings together cohorts from around the world to advance understanding of AD. Each cohort is poised to leverage the widespread use of mobile devices to integrate digital phenotyping into current methodologies and mitigate the lack of representativeness in AD research of racial and ethnic minorities across the globe. In addition to methods that these three cohorts are already using, DAC has developed a digital phenotyping protocol that can collect ADRD-related data remotely via smartphone and/or in clinic via a tablet to generate a common data elements digital dataset that can be harmonized with additional clinical and molecular data being collected at each cohort site and when combined across cohorts and made accessible can provide a global data resource that is more racially/ethnically represented of the world population.

Indexed as

biomarkersdigital technologieshealth disparityminority and vulnerable populations

Identifiers

PMID38034851
PMCPMC10687344
OpenAlexW4389211392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.